The road to universal coverage will be paved more slowly as the Obama administration comes to terms with the impact of the recession on the general economy, the national deficit, and RealHealthPolitik.
An interview with Peter Orszag in this morning’s Financial Times (London’s daily business newspaper) featured a sentence that gave me a double take; it was,
“The president has said he wants a path to universal coverage.”
A path is not an end-game or an outcome: it is a process, a journey. I believe that Orszag, the head budgeteer and Director at the Office of Management and Budget, carefully chose the word “path” for the interview with the FT.
The context for this is the deficit. When he was a Fellow at the Brookings Institution, Orszag told the City Club of Cleveland in a speech nearly five years ago in July 2004 that Medicare costs were the most significant driver of the long-term fiscal ill-health in the U.S.
Five years later, he tells the FT, “We have been very clear that a deficit-increasing health-care reform is neither practical nor desirable.”
Health Populi’s Hot Points: While Orszag said in his interview, “There are different ways of putting us on a path to universal coverage,” the uber-force isn’t universal coverage — it’s slowing down costs, or dare I say, “cost control?”
Orszag (and Obama, since Orszag speaks about these issues on the President’s behalf) is transparent about this reality. Embracing this priority can help stakeholder organizations in U.S. health care focus on plans that rationalize services and technologies, optimize cost-effectiveness, and deliver quality outcomes to as wide a population as practical. Health plan-service-product planners and marketers should adopt this lens on innovation for current projects in the pipeline and, especially, for new-new market introductions.




I'm gratified to be named on
I’m celebrating America’s 250th birthday both patriotically and professionally, honored that the NLM included my 2010 paper, “How Smartphones Are Changing Healthcare for Consumers and Patients” as one of 250 items curated for the digital archive of 250 Years of American Medicine.
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global health care enterprise.